BamHI drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (7)
Papers in which this entity is mentioned.
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Functional analysis of cancer-associated germline risk variants. (2025)
- UMI-linked consensus sequencing enables phylogenetic analysis of directed evolution. (2020)
- Genetic compensation triggered by mutant mRNA degradation. (2019)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. (2011)
- EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. (1998)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| bamhi | drug | 16 | 26 |